End-of-day quote
Korea S.E.
03:30:00 27/05/2024 am IST
5-day change
1st Jan Change
251
KRW
-1.18%
-7.72%
-10.68%
An unknown buyer agreed to acquire 6.1% stake in PangSky Co., Ltd. from Gold Pacific Co., Ltd. for KRW 2 billion.
An unknown buyer agreed to acquire 6.1% stake in PangSky Co., Ltd. from Gold Pacific Co., Ltd. (KOSDAQ:A038530) for KRW 2 billion on June 20, 2018. Under the terms of transaction the buyer will acquire 0.2 million shares at KRW 0.01 million each. Upon completion, Gold Pacific Co., Ltd. will not hold any stake in PangSky Co., Ltd. The transaction has been resolved by the Board of Gold Pacific Co., Ltd. The transaction is expected to be completed by June 20, 2018.
Gold Pacific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
12/23/12
CI
INCON Co.,Ltd. announced that it has received KRW 10 billion in funding from Gold Pacific Co., Ltd.
10/22/10
CI
Gold Pacific Co., Ltd. announced that it has received KRW 10.1 billion in funding
24/21/24
CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Ellim Corporation Co., Ltd. and other investors
19/21/19
CI
Gold Pacific Co., Ltd. agreed to acquire Distribution Business of CureBio Co.,Ltd. for KRW 6.5 billion.
01/21/01
CI
Gold Pacific Co., Ltd. announced that it has received KRW 8.001 billion in funding from Elim Corporation
09/21/09
CI
Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding
22/21/22
CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding
19/21/19
CI
Arthur Mine Fund and Flare Fund acquired 9.6% stake in Jokwang ILI Co., Ltd. from Gold Pacific Co., Ltd. for KRW 9.7 billion.
10/20/10
CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10.000084 billion in funding from Elim Corporation
12/20/12
CI
Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding from Chorokbaem Media Co., Ltd., Philosys Healthcare Co., Ltd
17/20/17
CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Chorokbaem Media Co., Ltd., Philosys Healthcare Co., Ltd
08/20/08
CI
Gold Pacific Co., Ltd. cancelled the acquisition of an additional 16.4% stake in Incon Co., Ltd. from H.Anderson Co., Ltd.
29/20/29
CI
Gold Pacific Co., Ltd. announced that it has received KRW 6 billion in funding
12/20/12
CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding
24/20/24
CI
Kim Woo-dong, Gold Pacific Co., Ltd. and two others completed the acquisition of 41.33% stake in Jokwang ILI Co., Ltd. from Lim Man-soo and five others.
14/19/14
CI
Cornerstone Networks CO., LTD announced that it has received KRW 1.5 billion in funding from Gold Pacific Co., Ltd.
12/19/12
CI
Kim Woo-dong, Gold Pacific Co., Ltd. and two others entered into an agreement to acquire 41.33% stake in Jokwang ILI Co., Ltd. from Lim Man-soo and five others for KRW 40.9 billion.
14/19/14
CI
Incon Co., Ltd. announced that it has received KRW 9 billion in funding from River Stone Co., Ltd., Gold Pacific Co., Ltd.
29/19/29
CI
Gold Pacific Co., Ltd. entered into an agreement to acquire an additional 16.4% stake in Incon Co., Ltd. from H.Anderson Co., Ltd. for KRW 44.2 billion.
29/19/29
CI
Gold Pacific Co., Ltd. completed the acquisition of Danaun Co., Ltd.
01/19/01
CI
Gold Pacific Co., Ltd. announced that it has received KRW 3.5 billion in funding
01/19/01
CI
Gold Pacific Co., Ltd. entered into an agreement to acquire Danaun Co., Ltd. for KRW 10.5 billion.
21/19/21
CI
An unknown buyer cancelled the acquisition of 6.1% stake in PangSky Co., Ltd. from Gold Pacific Co., Ltd..
20/19/20
CI
Incon Co., Ltd. announced that it expects to receive KRW 10.00000084 billion in funding from River Stone Co., Ltd., Gold Pacific Co., Ltd.
23/19/23
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
KBio Company Inc, formerly Gold Pacific Co Ltd, is a Korea-based company primarily engaged in the bio distribution business. The Company operates its business through three segments. The Bio Distribution segment is engaged in the supply of research reagents and consumables to each customer through hospitals, universities, research institutes, and dealers. The Fashion segment is engaged in the production and sale of products such as handmade leather goods, clothing, and accessories. The Other segment is engaged in the fashion promotion business and other businesses.
More about the company
1st Jan change
Capi.
-10.68% 21.49M -24.42% 10.96B +14.69% 6.34B -10.73% 6.08B -18.63% 6.05B +72.00% 4.98B -2.48% 4.64B -6.21% 4B -17.19% 3.28B -12.39% 2.86B
Other Drug Retailers
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1